These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11267578)

  • 1. Bioartificial liver support: report of the longest continuous treatment with human hepatocytes.
    Millis JM; Cronin DC; Johnson R; Conjeevaram H; Faust TW; Trevino S; Conlin C; Brotherton J; Traglia D; Maguire P; Dane G
    Transplant Proc; 2001; 33(1-2):1935. PubMed ID: 11267578
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced encephalopathy in pigs with ischemia-induced acute hepatic failure treated with a bioartificial liver containing alginate-entrapped hepatocytes.
    Desille M; Mahler S; Seguin P; Mallédant Y; Frémond B; Sébille V; Bouix A; Desjardins JF; Joly A; Desbois J; Lebreton Y; Campion JP; Clément B
    Crit Care Med; 2002 Mar; 30(3):658-63. PubMed ID: 11990930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental study of plasma recycling system by off-line bioartificial liver in rats.
    Ikeda T; Aoki T; Miyashita T; Kasuya K; Tsuchida A; Koyanagi Y; Matsumura T; Suzuki S; Enosawa S
    Transplant Proc; 2002 Nov; 34(7):2706-10. PubMed ID: 12431582
    [No Abstract]   [Full Text] [Related]  

  • 4. [Application of bioartificial liver in the treatment of hepatic failure].
    Wang YJ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):504. PubMed ID: 12939192
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of continuous human liver support.
    Millis JM; Cronin DC; Johnson R; Conjeevaram H; Brady L; Trevino S; Conlin C; Brotherton J; Traglia D; Dane G; Maguire P
    Transplant Proc; 2001; 33(1-2):1954. PubMed ID: 11267585
    [No Abstract]   [Full Text] [Related]  

  • 6. Temporary neurological improvement in a patient with acute or chronic liver failure treated with a bioartificial liver device.
    Donini A; Baccarani U; Risaliti A; Degrassi A; Bresadola F
    Am J Gastroenterol; 2000 Apr; 95(4):1102-4. PubMed ID: 10763984
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver support in acute liver failure.
    Hughes RD
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):547-8. PubMed ID: 14531165
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of bioartificial liver in pigs with total ischemic liver failure.
    Kamohara Y; Tsutsumi R; Kawazoe Y; Miyamoto S; Moriuchi H; Tamura T; Eguchi S; Kawashita Y; Azuma T; Fujioka H; Furui J; Kanematsu T
    Transplant Proc; 2000 Nov; 32(7):2343-4. PubMed ID: 11120193
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term survivors with artificial liver support in fulminant hepatic failure.
    Nitta M; Hirasawa H; Oda S; Shiga H; Nakanishi K; Matsuda K; Nakamura M; Yokohari K; Hirano T; Hirayama Y; Moriguchi T; Watanabe E
    Ther Apher; 2002 Jun; 6(3):208-12. PubMed ID: 12109945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bile acids in patients with liver failure supported with a bioartificial liver.
    Pazzi P; Morsiani E; Vilei MT; Granato A; Rozga J; Demetriou AA; Muraca M
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1547-54. PubMed ID: 12182755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The development and status of bioartificial liver].
    Li GL; Wang SM
    Zhonghua Wai Ke Za Zhi; 2017 Dec; 55(12):957-959. PubMed ID: 29224272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promise of artificial liver replacement.
    Pryor HI; Vacanti JP
    Front Biosci; 2008 Jan; 13():2140-59. PubMed ID: 17981698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal treatment in fulminant hepatic failure: pathophysiologic considerations.
    Kramer L; Bauer E
    Int J Artif Organs; 2002 Oct; 25(10):929-34. PubMed ID: 12456033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of the neurological status of pigs with acute liver failure by hepatocytes immobilized in alginate gel beads inoculated in an extracorporeal bioartificial liver.
    Desille M; Frémond B; Mahler S; Mallédant Y; Seguin P; Bouix A; Lebreton Y; Desbois J; Campion JP; Clément B
    Transplant Proc; 2001; 33(1-2):1932-4. PubMed ID: 11267577
    [No Abstract]   [Full Text] [Related]  

  • 15. Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.
    Naruse K; Tang W; Makuuch M
    World J Gastroenterol; 2007 Mar; 13(10):1516-21. PubMed ID: 17461442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of artificial liver support in hepatic encephalopathy.
    Stadlbauer V; Wright GA; Jalan R
    Metab Brain Dis; 2009 Mar; 24(1):15-26. PubMed ID: 19101787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioartificial liver support anno 2001.
    Chamuleau RA
    Metab Brain Dis; 2002 Dec; 17(4):485-91. PubMed ID: 12602524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2.
    Enosawa S; Miyashita T; Tanaka H; Li X; Suzuki S; Amemiya H; Omasa T; Suga K; Matsumura T
    Transplant Proc; 2001; 33(1-2):1945-7. PubMed ID: 11267581
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of liver failure using tissue engineering techniques].
    Pokrywczyńska M; Drewa T
    Pol Merkur Lekarski; 2007 Jul; 23(133):66-9. PubMed ID: 18051833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal liver perfusion.
    McChesney LP; Fagan EA; Rowell DL; Del Rio JV; Fabrega F; Millis M; Williams JW
    Lancet; 1999 Jan; 353(9147):120-1. PubMed ID: 10023904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.